Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Sell
41
SBHMY Quote, Financials, Valuation and Earnings
Last price:
$8.79
Seasonality move
:
7.63%
Day range:
$8.79 - $8.79
52-week range:
$6.69 - $10.30
Dividend yield:
2.33%
P/E ratio:
16.53x
P/S ratio:
2.00x
P/B ratio:
1.83x
Volume:
--
Avg. volume:
151
1-year change:
22.08%
Market cap:
$8B
Revenue:
$4B
EPS (TTM):
$0.53
Earnings Data
Next earnings date for SBHMY
Aug 13
2025
Most recent earnings per share
$0.15
Beat by $0.15
(Mar 23/2021)
Consensus Estimate
--
(Mar 23/2021)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SBHMY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2021 | Q4 | -- | -- | $0.15 | -- | -- |
| 11/30/2020 | Q3 | -- | -- | $0.09 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | $0.05 | -- | -- |
| 04/21/2020 | Q1 | -- | -- | $0.13 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.08 | -- | -- |
| 11/26/2019 | Q3 | -- | -- | $0.12 | -- | -- |
| 09/27/2019 | Q2 | -- | -- | $0.09 | -- | -- |
| 05/21/2019 | Q1 | -- | -- | $0.13 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $1.07 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.13 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.10 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.09 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.08 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.12 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $0.06 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.07 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.04 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $0.05 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.05 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.07 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $0.05 | -- | -- |
Sino Biopharmaceutical Earnings Questions
-
How Much did Sino Biopharmaceutical Generate in Revenue Last Quarter?
Sino Biopharmaceutical reported -- worth of top line sales in its most recent quarter.
-
Did Sino Biopharmaceutical Beat Earnings Last Quarter?
Sino Biopharmaceutical announced earnings per share of $0.15 which represents a beat of analyst forecast a -- per share.
-
Is Sino Biopharmaceutical Profitable?
Sino Biopharmaceutical reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sino Biopharmaceutical EPS Next Year?
Sino Biopharmaceutical's earnings are forecast to grow from $0.53 per share to -- per share next year representing an increase of --.
-
When is Sino Biopharmaceutical's Earnings Date?
Sino Biopharmaceutical's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 14
Regencell Bioscience Holdings [RGC] is down 11.8% over the past day.
Buy
52
SLP alert for Apr 14
Simulations Plus [SLP] is up 4.69% over the past day.
Sell
38
ZLAB alert for Apr 14
Zai Lab [ZLAB] is up 6.77% over the past day.
